As of November 2024, Neuren Pharmaceuticals has a market cap of $1.19B. This makes Neuren Pharmaceuticals the world's 7087th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.02B | -7.69% |
2023 | $2.19B | 214.09% |
2022 | $697.40M | 110.88% |
2021 | $330.72M | 193.39% |
2020 | $112.72M | -48.19% |
2019 | $217.55M | 77.14% |
2018 | $122.81M | -56.25% |
2017 | $280.72M | 175.86% |
2016 | $101.76M | -49.57% |
2015 | $201.76M | -4.17% |
2014 | $210.54M | 4.35% |
2013 | $201.76M | 228.57% |
2012 | $61.41M | 29.63% |
2011 | $47.37M | 86.21% |
2010 | $25.44M | -56.76% |
2009 | $58.83M | 270.00% |
2008 | $15.90M | -94.44% |
2007 | $286.20M | -54.31% |
2006 | $626.35M | -25.67% |
2005 | $842.69M | - |